HealthStream (HSTM) Panoramica del titolo
HealthStream, Inc. fornisce applicazioni basate su Software-as-a-Service (SaaS) per le organizzazioni sanitarie negli Stati Uniti. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 1/6 |
| Prestazioni passate | 2/6 |
| Salute finanziaria | 5/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
HSTM ha superato i nostri controlli di rischio.
HSTM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di HealthStream, Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$26.73 |
| Massimo di 52 settimane | US$29.63 |
| Minimo di 52 settimane | US$19.50 |
| Beta | 0.47 |
| Variazione di 1 mese | 10.23% |
| Variazione a 3 mesi | 26.68% |
| Variazione di 1 anno | -2.98% |
| Variazione a 3 anni | 8.84% |
| Variazione a 5 anni | -3.81% |
| Variazione dall'IPO | 214.47% |
Notizie e aggiornamenti recenti
HSTM: Buybacks And Updated Assumptions Will Shape Balanced Future Share Performance
Analysts have raised their price target on HealthStream by $3. They cite updated views on its fair value and revised assumptions for the discount rate, revenue growth, profit margins, and future P/E.HSTM: AI Disruption Risks And Buybacks Will Shape Future Share Performance
Analysts have raised their fair value estimate for HealthStream from $21.00 to $24.00, citing updated views on the company’s discount rate, revenue growth, profit margins, and future P/E assumptions reflected in recent Street research. Analyst Commentary Street research around HealthStream has become more mixed, even as some firms lift price targets.Recent updates
HSTM: Buybacks And Updated Assumptions Will Shape Balanced Future Share Performance
Analysts have raised their price target on HealthStream by $3. They cite updated views on its fair value and revised assumptions for the discount rate, revenue growth, profit margins, and future P/E.HSTM: AI Disruption Risks And Buybacks Will Shape Future Share Performance
Analysts have raised their fair value estimate for HealthStream from $21.00 to $24.00, citing updated views on the company’s discount rate, revenue growth, profit margins, and future P/E assumptions reflected in recent Street research. Analyst Commentary Street research around HealthStream has become more mixed, even as some firms lift price targets.HSTM: AI Disruption Risks And Capital Returns Will Drive Future Share Performance
Narrative Update on HealthStream Analysts have reset their price target on HealthStream to $21 from $25, citing respectable 4Q'25 results and management's detailed response to AI-related risks. They view this as leaving the company relatively better positioned than many other SaaS peers.
HSTM: AI Risk Positioning And Capital Returns Will Support Upside Potential
Analysts have reduced the fair value estimate for HealthStream from $34.00 to $30.50, citing a lower forward P/E assumption and an increased discount rate, while also referencing recent Street research that trimmed the price target to $21 and highlighted both respectable 4Q'25 results and management's case that the company is relatively well positioned against AI-related risks in SaaS. Analyst Commentary Recent Street commentary on HealthStream focuses on how the company is handling AI related risks in SaaS and what that could mean for valuation and execution.HSTM: AI Disruption Risks And Capital Returns Will Shape Future Outlook
Analysts have reset their price target on HealthStream to $21, down from $25, after incorporating fresh views on AI-related risks and management's argument that the company is relatively well positioned compared with other SaaS names. Analyst Commentary Bearish analysts have trimmed expectations on HealthStream by cutting the price target to $21 from $25, while maintaining a neutral stance on the shares.HSTM: AI Risks, Capital Returns And Fair Value Will Shape Outlook
Analysts have reduced their price target on HealthStream to $21 from $25, citing a recalibration of fair value, discount rate and future P/E assumptions, while also highlighting management's view that the business model remains relatively well positioned against rising AI related concerns for SaaS names. Analyst Commentary Bearish analysts are signaling a more cautious stance on HealthStream after the latest quarterly update.HSTM: Dividend Hike And Buyback Will Support Future Upside Potential
Analysts have kept their $25.00 price target for HealthStream unchanged, citing only slight tweaks to assumptions around the discount rate, revenue growth, profit margin, and future P/E that together do not materially shift their overall view on the stock. What's in the News The board approved a quarterly cash dividend of US$0.035 per share, a 12.9% increase from the prior US$0.031, payable on March 20, 2026, to shareholders of record on March 9, 2026 (company announcement).HSTM: Fine Tuned Assumptions Will Support Future Upside Potential
Analysts kept their fair value estimate for HealthStream at $25.00, with modest tweaks to inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions. This underpins the unchanged price target and reflects only fine tuning in their models rather than a shift in overall view.HealthStream, Inc. (NASDAQ:HSTM) Investors Are Less Pessimistic Than Expected
HealthStream, Inc.'s ( NASDAQ:HSTM ) price-to-earnings (or "P/E") ratio of 28.8x might make it look like a sell right...HSTM: Share Repurchases And Acquisition Efforts Will Drive Future Upside
Analysts now place their fair value estimate for HealthStream at US$25.00. The updated target reflects small tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions in their models.HSTM: Share Buybacks And M&A Activity Will Support Future Upside
Analysts have trimmed their fair value estimate for HealthStream from US$28 to about US$25. They cite updated assumptions on discount rates, revenue growth, profit margins, and a lower future P/E multiple in their refreshed models.Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...A Look At The Intrinsic Value Of HealthStream, Inc. (NASDAQ:HSTM)
Key Insights Using the 2 Stage Free Cash Flow to Equity, HealthStream fair value estimate is US$29.23 With US$24.60...HealthStream: High-Quality Business At A Fair Price
Summary HealthStream boasts a resilient, founder-led SaaS business model with decades of profitable growth, strong balance sheet, and shareholder-friendly capital returns. Revenue is highly recurring and predictable due to long-term, non-cancelable contracts, with built-in price escalators and industry-leading products recognized by G2. Short-term headwinds include funding cuts, customer bankruptcy, and delayed revenue recognition, prompting a downward revision in 2025 guidance, but technical issues are seen as temporary. Transition to SaaS and platform offerings positions HealthStream for higher margins and future growth, with most products tied to essential, mandatory healthcare requirements. Despite strong fundamentals, the stock remains expensive on a P/E basis but appears fairly valued on a P/S basis; thus, I rated it as HOLD overall, with a small starter position reflecting my long-term confidence in the business. Read the full article on Seeking AlphaWe Discuss Why The CEO Of HealthStream, Inc. (NASDAQ:HSTM) Is Due For A Pay Rise
Key Insights HealthStream's Annual General Meeting to take place on 29th of May Total pay for CEO Bobby Frist includes...HealthStream (NASDAQ:HSTM) Is Doing The Right Things To Multiply Its Share Price
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...Should You Be Adding HealthStream (NASDAQ:HSTM) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Returns At HealthStream (NASDAQ:HSTM) Are On The Way Up
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
Navigating Temporary Challenges, The Company Sets Its Sights On Long-term Revenue Growth And Market Expansion
Expansion into the health plan market and strong sales pipelines in key products signal potential for revenue growth and customer base diversification.HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...Rendimenti per gli azionisti
| HSTM | US Healthcare Services | US Mercato | |
|---|---|---|---|
| 7D | 4.3% | 8.8% | -2.6% |
| 1Y | -3.0% | -43.3% | 20.0% |
Ritorno vs Industria: HSTM ha superato il US Healthcare Services che ha restituito -43.3 % nell'ultimo anno.
Rendimento vs Mercato: HSTM ha avuto una performance inferiore al mercato US che ha registrato un rendimento 20 % nell'ultimo anno.
Volatilità dei prezzi
| HSTM volatility | |
|---|---|
| HSTM Average Weekly Movement | 5.8% |
| Healthcare Services Industry Average Movement | 10.1% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Prezzo delle azioni stabile: HSTM non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 6% ) di HSTM è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1990 | 1,150 | Bobby Frist | www.healthstream.com |
HealthStream, Inc. fornisce applicazioni basate su Software-as-a-Service (SaaS) per le organizzazioni sanitarie negli Stati Uniti. L'azienda offre hStream, una piattaforma tecnologica; CredentialStream, che fornisce alle organizzazioni sanitarie strumenti per supportare la gestione del ciclo di vita dei fornitori, dal reclutamento, alla presentazione delle domande, alla verifica delle licenze e di altre credenziali, al privilegio, alle nomine da parte dei comitati per le credenziali, all'iscrizione, alla rete, alla gestione, all'onboarding e alla valutazione delle prestazioni dei fornitori; ShiftWizard; e Competency Suite, un sistema per lo sviluppo delle competenze cliniche basato sull'AI/ML. Fornisce inoltre applicazioni per la valutazione delle prestazioni, la gestione delle competenze, la gestione della divulgazione, le competenze cliniche, la valutazione, lo sviluppo, l'istruzione basata sulla simulazione, la rotazione clinica e la gestione dell'onboarding, la gestione della qualità e la formazione industriale.
HealthStream, Inc. Riepilogo dei fondamenti
| HSTM statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$750.83m |
| Utili (TTM) | US$19.92m |
| Ricavi(TTM) | US$311.78m |
HSTM è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| HSTM Conto economico (TTM) | |
|---|---|
| Ricavi | US$311.78m |
| Costo del fatturato | US$109.48m |
| Profitto lordo | US$202.30m |
| Altre spese | US$182.38m |
| Utili | US$19.92m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 0.68 |
| Margine lordo | 64.89% |
| Margine di profitto netto | 6.39% |
| Rapporto debito/patrimonio netto | 0% |
Come si è comportato HSTM nel lungo periodo?
Vedi performance storica e confrontoDividendi
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/06/26 18:51 |
| Prezzo dell'azione a fine giornata | 2026/06/26 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
HealthStream, Inc. è coperta da 11 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Matthew Gillmor | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Richard Close | Canaccord Genuity |